This story has been updated from a previous version to include comments from Sequenom's earnings call.

NEW YORK (GenomeWeb News) – Sequenom reported after the close of the market Thursday that its fourth quarter revenues climbed 34 percent from the fourth quarter of 2012, driven by sales of its MaterniT21 Plus test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.